Abstract:Objective To discuss the diagnosis, treatment and prognosis of stage Ⅲ osteosarcoma. Methods A retrospective analysis of 23 patients with stage Ⅲ osteosarcoma of extremities from December 1989 to December 2003 was studied. There were 9 females and 14 males, aging from 16 to 31 years with a mean of 22.4 years. 15 patients presented with lung metastases, 7 with bone metastases (including 5 of jumping metastases and 2 of osteosarcomas) and 1 with lung and bone metastases simultaneously. Patients received chemotherapy followed by resection of primary and metastatic lesions and additional chemotherapy. Results After preoperative chemotherapy, lung metastases disappeared in 1 patient, whereas in 1 with lung and bone metastases simultaneously, the lesion remained surgically unresectable because of new metastases after removal of the primary lesion. In 2 patients with osteosarcoma, primary lesion could only be removed, lung metastasis appeared in 2 of 5 patients with jumping metastases respectively after the removal of primary lesion and jumping metastases. 16 patients with lung metastases received thoracotomy and resection of the lung metastatic lesions, and 6 of them received a second thoracotomy because of a second lung metastasis inclunding 3 cases with extra-pulmonary metastases without any additional treatment. The tumor necrosis rate was not found obviously different between primary lesions and metastatic lesions. Of the 23 patients who achieved a mean 74.6 months follow-up (range, 5-168 months), 9 remained continuously free of disease, 4 relapsed with new metastases, and 10 died of tumors. The outcome of the Cox model proportional hazard regression showed the relation of the number of the metastases and the prognosis were significant(P0.05). Using log-rank method, no obviously difference between the Kaplan-Meier survival curve of the patients with lung metastases and that of the jumping metastases was found. Conclusion The combination of neoadjuvant chemotherapy and resection of the primary and metastatic lesions is effective. The median incision of the sternum during the first resection of the lung metastatic lesions is recommended . The number of the metastatic lesions is significantly correlated with the prognosis.

Clinical features and prognosis of osteosarcoma in elderly patients

Clinical Features and Prognostic Factors in Elderly Ewing Sarcoma Patients.

The diuleal features and prognostic factors of osteosarcoma in adult

Osteosarcoma in Elderly Patients: a Report of 10 Cases

Characteristics and Prognostic Factors of Patients with Osteosarcoma Older Than 60 Years from the SEER Database

The Treatment of Stage III Osteosarcoma

Surgical Treatment and Prognostic Analysis of Osteosarcoma in Adults Older Than 40 Years

Primary Osteosarcoma in Elderly Patients: A Report of Three Cases

The clinical features and prognostic factors of osteosarcoma in adult.

The Role of Chemotherapy in the Survival Benefits of Patients Aged Older Than 40 Years With Osteosarcoma

Retrospective Analysis of Clinical Differences between Preadolescent and Young Adult Patients with Osteosarcoma and Their Prognostic Factors

COX Proportional-Hazard Regression Analysis of Prognostic Factors in 52 Adult Patients with Osteosarcoma

Predictors of the Survival of Primary and Secondary Older Osteosarcoma Patients

Correlation Study Between Advanced Age and Inferior Prognosis in Stage Ⅱ Colorectal Cancer Patients

Ten-year follow-up of the chemotherapy,surgery and prognosis for 413 cases of osteosarcoma

Analysis of Prognostic Factors in 333 Chinese Patients with High-Grade Osteosarcoma Treated by Multidisciplinary Combined Therapy.

Clinicopathologic features of primary osteosarcoma in adults: A report of 98 patients over 30 years of age

Clinicopathological characteristics and prognostic factors of pulmonary sarcomatoid carcinoma: a large population analysis

Retrospective analysis of clinical differences and prognostic factors in 32 patients with maxillofacial osteosarcoma

Clinical Factors Affecting Prognosis of Limb Osteosarcoma in China: a Multicenter Retrospective Analysis.

Survival Analysis of 311 Patients with Osteosarcoma of the Extremities Treated in a Single Institute